1. Effects of once-weekly semaglutide on coronary outcomes in patients with type 2 diabetes mellitus with or at high risk for cardiovascular disease: insights from the SUSTAIN-6 trial. (11th May 2022) Authors: Kolkailah, A; Aharonovich, A; Lingvay, I; Dobrecky-Mery, I; Rasmussen, S; Tetens Hoff, S; Mcguire, DK Journal: European journal of preventive cardiology Issue: Volume 29(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗